Insider Transactions in Q4 2020 at Checkmate Pharmaceuticals, Inc. (CMPI)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 29
2020
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
443
+0.06%
|
$6,202
$14.16 P/Share
|
|
Dec 22
2020
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
5,103
+0.69%
|
$71,442
$14.64 P/Share
|
|
Dec 22
2020
|
Kleem Chaudhary Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+50.0%
|
$8,000
$2.62 P/Share
|
|
Dec 16
2020
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
4,805
+0.66%
|
$67,270
$14.62 P/Share
|
|
Dec 15
2020
|
Arthur M Krieg Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
42
+0.01%
|
$588
$14.49 P/Share
|